Evidence map›Paper›PMID 24248178›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2014

Serum sclerostin levels vary with season.

Bess Dawson-Hughes, Susan S Harris, Lisa Ceglia, Nancy J Palermo

Abstract readClinical Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. An In-Depth Analysis of Variable Dynamics Influencing Bone Mineral Density in Transfusion-Dependent Thalassemia Patients.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Serum sclerostin levels in osteoporotic fracture patients.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2022
    Article
  9. Article
  10. Romosozumab: a novel bone anabolic treatment option for osteoporosis?Wiener medizinische Wochenschrift (1946) · 2020
    Article
  11. Review
  12. Article
  13. Article
  14. Effect of Qing'e formula on circulating sclerostin levels in patients with postmenopausal osteoporosis.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2015
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bess Dawson-HughesJean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging (B.D.-H., S.S.H., L.C., N.J.P.), Tufts University, and Division of Endocrinology, Diabetes, and Metabolism (B.D.-H., L.C.), Tufts Medical Center, Boston, Massachusetts 02111.
Susan S Harris
Lisa Ceglia
Nancy J Palermo

Funding

EFFECT OF CALCIUM AND VITAMIN D ON BONE LOSS FROM HIPU01AG010353 · NIA · TUFTS UNIVERSITY BOSTON · PI DAWSON-HUGHES, BESS · 1991 to 1998
–
NIA NIH HHS AG10353NIA NIH HHS U01 AG010353
6 · The paper itself

Abstract

contextTo establish the clinical utility of serum sclerostin levels, it is important to know whether there is seasonal variation in the measurements.

objectiveThis study was done to determine whether serum sclerostin levels vary by season in healthy older men and women.

methodsSerum sclerostin levels were measured in archived serum of 314 healthy men and women aged 65 years and older and examined for seasonal variation. Several factors known to vary by season and previously reported to be associated with serum sclerostin levels, including serum osteocalcin, physical activity, and serum PTH levels, were also measured in these subjects. Sex did not modify the association of season with sclerostin, so the men and women were analyzed together.

resultsSerum sclerostin levels varied significantly by season (P < .001, after adjustment for sex). Sclerostin levels in the wintertime were 20% higher than the all-year mean, the levels gradually declined through the spring and summer, and by the fall, they were 20% below the all-year mean. Adjustment for serum osteocalcin, physical activity, and serum PTH did not alter the seasonal means. Seasonal differences in serum osteocalcin, physical activity, and serum PTH were not statistically significant.

conclusionsThis study documents marked seasonal variation in serum sclerostin levels. It is important to recognize this source of biological variability when considering the potential clinical utility of sclerostin measurements.

Indexed as

SeasonsAdaptor Proteins, Signal TransducingAgedAged, 80 and overBone Morphogenetic ProteinsFemaleGenetic MarkersHumansMaleReference ValuesAdaptor Proteins, Signal TransducingBone Morphogenetic ProteinsGenetic MarkersSOST protein, human

Identifiers

PMID24248178
PMCPMC3879665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.